|
|
|
|
|
|
|
Pulse Biosciences CS (PLSE)
|
|
17.7 -0.68 (-3.7%)
|
04-23 16:00
|
|
Open:
|
18.51
|
Pre. Close:
|
18.38
|
|
High:
|
18.51
|
Low:
|
17.1
|
|
Volume:
|
147,184
|
Market Cap:
|
299M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
18.53 - 18.681
|
18.681 - 18.783
|
|
Low:
|
16.804 - 16.961
|
16.961 - 17.067
|
|
Close:
|
17.488 - 17.739
|
17.739 - 17.907
|
|
|
|
Technical analysis (as of: 2018-04-23 4:32:21 PM)
|
|
Overall:
|
|
|
Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.
|
|
Target:
|
Six months: 26.28 One year: 30.70
|
|
Support:
|
Support1: 16.34 Support2: 12.53
|
|
Resistance:
|
Resistance1:
22.50 Resistance2: 26.28
|
|
Pivot:
|
18.07 
|
|
Moving Averages:
|
MA(5): 18.75  MA(20): 16.90
MA(100): 19.81 MA(250): 22.93
|
|
MACD:
|
MACD(12,26):
0.67 Signal(12,26,9): 0.49
|
|
%K %D:
|
%K(14,3): 53.98 %D(3): 61.12
|
|
RSI:
|
RSI(14): 51.23
|
|
52-Week:
|
High: 39.5
Low: 9.811 Change(%): -29.1
|
|
Average Vol(K):
|
3-Month: 16274
10-Days 27500
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.PLSE has closed above bottom band by 43.6%. Bollinger Bands are 22.9% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
2018-04-18T16:00:00-04:00
Pulse Biosciences Grants Equity Incentive Awards to New Employee
2018-04-17T02:14:33-04:00
Biotech Analysis Central Pharma News: GlaxoSmithKline Passes Along Pipeline, Pulse Impresses, Celldex's Failure
2018-04-16T08:00:00-04:00
Your Daily Pharma Scoop: Intercept's OCA, MediciNova In NASH, Pulse Biosciences Data
2018-04-13T12:52:34-04:00
Midday Gainers / Losers (04/13/2018)
2018-04-13T09:18:25-04:00
Premarket Gainers as of 9:05 am (04/13/2018)
2018-04-13T08:30:52-04:00
Pulse Bio's NPS technology shows positive effect in eliminating skin growths; shares up 13% premarket
2018-04-12T17:19:00-04:00
Pulse Biosciences Announces Positive Results from Its First Study Evaluating a Clinical Target at Major Scientific Meeting
2018-04-05T12:43:55-04:00
Midday Gainers / Losers (4/5/2018)
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
NA
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
